Clinical trial · Interventional
Comparing Aerobic to Resistance Training in Recovery From Cancer
NCT00237926CI-TRIAL-00001633completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to compare the health outcomes of a 12-week exercise program focused on aerobic training (using a treadmill) to a 12-week exercise program focused on resistance training (using Thera-Bands) in sedentary patients within 6 months of completing treatment for cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Neoplasms | Neoplasm | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Exercise | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- 1
- description
- aerobic exercise
- interventionNames
- Behavioral: Exercise
- type
- EXPERIMENTAL
- label
- 2
- description
- Resistance Training
- interventionNames
- Behavioral: Exercise
Primary outcomes (1)
- measure
- quality of life
- timeFrame
- 12-weeks
Secondary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * have a biopsy-proven cancer diagnosis * be within six months of having completed chemotherapy or radiation therapy for treatment for cancer as determined by the primary physician * be ambulatory but sedentary (i. e., has not followed an exercise regimen of a minimum of 3 times per week for at least 20 minutes each session over the previous six weeks) * have an Eastern Cooperative Oncology Group (ECOG) Performance Status score of 0 asymptomatic) or 1 (symptomatic, fully ambulatory) * be at least 18 years old * be able to read and speak English * have a medical statement from either the patient's primary care provider or the primary oncologist indicating that participation in the program is not medically contraindicated Exclusion Criteria: * following an exercise regimen a minimum of 3 times per week for at least 20 minutes each session within the previous 6 weeks * bone or joint destruction that could be aggravated with exercise * severe cognitive impairment identified by either the patient's medical care provider or by the study team * neuropathy-sensory common toxicity criteria (CTC) grade 3 (sensory loss or paresthesia interfering with activities of daily living) or grade 4 (permanent sensory loss that interferes with function) peripheral neuropathy
References
Publications (0)
Data not yet available
No reference posted for this study.